Literature DB >> 29789938

Meta-analysis of physical activity and effects of social function and quality of life on the physical activity in patients with schizophrenia.

Kazutaka Ohi1,2, Yuzuru Kataoka3, Takamitsu Shimada3, Aki Kuwata3, Hiroaki Okubo3, Kohei Kimura3, Toshiki Yasuyama3, Takashi Uehara3, Yasuhiro Kawasaki3.   

Abstract

Schizophrenia patients have increased mortality and morbidity, mainly due to premature cardiovascular disease resulting from decreased physical activity (PA). However, which PA intensity is impaired in the patients and how factors such as social function and quality of life (QoL) are related to decreased PA is unknown. To assess PA, social function and QoL, the International Physical Activity Questionnaire (IPAQ), Social Functioning Scale (SFS) and Schizophrenia Quality of Life Scale (SQLS), respectively, were used in 109 schizophrenia patients and 69 healthy subjects. A meta-analysis comparing PA intensities (vigorous, moderate and light) assessed by the single PA measurement between schizophrenia patients and healthy subjects after including our case-control sample was performed. Furthermore, the effects of social function and QoL on each level of PA intensity were investigated in patients and controls. The meta-analysis in 212 schizophrenia patients and 132 healthy subjects revealed that patients showed lower total PA, particularly vigorous PA, than controls (I2 = 0, Hedges' g = - 0.41, P = 2.80 × 10-4). The decreased total PA was correlated with impaired total SFS scores (β = 0.24, P = 2.86 × 10-3), withdrawal (β = 0.23, P = 3.74 × 10-3) and recreation (β = 0.23, P = 3.49 × 10-3) without significant heterogeneity between patients and controls. In contrast, the decreased total PA was affected by low independence-performance (β = 0.22, P = 0.034), employment/occupation (β = 0.27, P = 8.74 × 10-3), psychosocial (β = - 0.24, P = 0.021) and motivation/energy (β = - 0.26, P = 0.013), but only in patients. Similar findings were obtained for vigorous PA but not moderate or light PA. Our findings suggest that the impaired vigorous PA in schizophrenia patients may be mediated by schizophrenia-specific factors of social functioning and QoL. Understanding these factors has important implications for increasing PA participation in schizophrenia patients.

Entities:  

Keywords:  Meta-analysis; Physical activity; Quality of life; Schizophrenia; Social function

Mesh:

Year:  2018        PMID: 29789938     DOI: 10.1007/s00406-018-0903-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  47 in total

1.  Compendium of physical activities: an update of activity codes and MET intensities.

Authors:  B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon
Journal:  Med Sci Sports Exerc       Date:  2000-09       Impact factor: 5.411

Review 2.  Correlates of adults' participation in physical activity: review and update.

Authors:  Stewart G Trost; Neville Owen; Adrian E Bauman; James F Sallis; Wendy Brown
Journal:  Med Sci Sports Exerc       Date:  2002-12       Impact factor: 5.411

3.  Schizophrenia Quality of Life Scale: validation of the Japanese version.

Authors:  Yasuhiro Kaneda; Akira Imakura; Akira Fujii; Tetsuro Ohmori
Journal:  Psychiatry Res       Date:  2002-12-15       Impact factor: 3.222

4.  International physical activity questionnaire: 12-country reliability and validity.

Authors:  Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja
Journal:  Med Sci Sports Exerc       Date:  2003-08       Impact factor: 5.411

5.  Validation of a physical activity assessment tool for individuals with schizophrenia.

Authors:  Guy Faulkner; Tony Cohn; Gary Remington
Journal:  Schizophr Res       Date:  2005-12-19       Impact factor: 4.939

Review 6.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

7.  The impact of weight gain on quality of life among persons with schizophrenia.

Authors:  David B Allison; Joan A Mackell; Diana D McDonnell
Journal:  Psychiatr Serv       Date:  2003-04       Impact factor: 3.084

8.  Self-report quality of life measure for people with schizophrenia: the SQLS.

Authors:  G Wilkinson; B Hesdon; D Wild; R Cookson; C Farina; V Sharma; R Fitzpatrick; C Jenkinson
Journal:  Br J Psychiatry       Date:  2000-07       Impact factor: 9.319

9.  Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol.

Authors:  Toshiya Inada; Gohei Yagi; Sadanori Miura
Journal:  Schizophr Res       Date:  2002-10-01       Impact factor: 4.939

10.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.

Authors:  Patrick F Sullivan; Kenneth S Kendler; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2003-12
View more
  7 in total

1.  Aerobic exercise in mental disorders: from basic mechanisms to treatment recommendations.

Authors:  Andrea Schmitt; Daniela Reich-Erkelenz; Alkomiet Hasan; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08       Impact factor: 5.270

2.  A Retrospective Study on the Relationship Between Cognitive Function and Social Function in Patients With Schizophrenia.

Authors:  Takamitsu Shimada; Genyo Kobayashi; Yoshihiro Saeki; Chikako Mizukoshi; Kazuo Chikazawa; Katsutoshi Nokura; Mitsuru Hasegawa; Tamami Maeda; Yoshiki Maeda; Yasuhiro Kawasaki
Journal:  J Clin Med Res       Date:  2022-09-29

3.  A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia.

Authors:  Kazutaka Ohi; Chika Sumiyoshi; Haruo Fujino; Yuka Yasuda; Hidenaga Yamamori; Michiko Fujimoto; Tomiki Sumiyoshi; Ryota Hashimoto
Journal:  Front Psychiatry       Date:  2019-08-09       Impact factor: 4.157

4.  Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls.

Authors:  Kazutaka Ohi; Miori Ishibashi; Kaai Torii; Mayuka Hashimoto; Yurika Yano; Toshiki Shioiri
Journal:  J Psychiatry Neurosci       Date:  2022-03-01       Impact factor: 6.186

5.  Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.

Authors:  Kazutaka Ohi; Daisuke Nishizawa; Takamitsu Shimada; Yuzuru Kataoka; Junko Hasegawa; Toshiki Shioiri; Yasuhiro Kawasaki; Ryota Hashimoto; Kazutaka Ikeda
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-21       Impact factor: 5.176

6.  Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants.

Authors:  Yuzuru Kataoka; Takamitsu Shimada; Yoko Koide; Hiroaki Okubo; Takashi Uehara; Toshiki Shioiri; Yasuhiro Kawasaki; Kazutaka Ohi
Journal:  Int J Neuropsychopharmacol       Date:  2020-07-21       Impact factor: 5.176

7.  The Impact of the COVID-19 Pandemic on the Lifestyles and Levels of Anxiety and Depression of Patients with Schizophrenia: A Retrospective Observational Study.

Authors:  Gemma Biviá-Roig; Pau Soldevila-Matías; Gonzalo Haro; Victor González-Ayuso; Francisco Arnau; Loreto Peyró-Gregori; Laura García-Garcés; Maria I Sánchez-López; Juan Francisco Lisón
Journal:  Healthcare (Basel)       Date:  2022-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.